National Center for Complementary and Alternative Medicine; Notice of Meeting, 74727-74728 [E8-29030]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 237 / Tuesday, December 9, 2008 / Notices
Date: January 26–27, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Serrano Hotel, 405 Taylor Street,
San Francisco, CA 94102.
Contact Person: Martha Faraday, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
MSC 7808, Bethesda, MD 20892, 301–435–
3575, faradaym@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Surgery,
Anesthesiology and Trauma Study Section.
Date: January 28–29, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Weihua Luo, MD, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Developmental Brain Disorders Study
Section.
Date: January 29–30, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Pat Manos, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5200, MSC 7846, Bethesda, MD
20892, 301–435–1785, manospa@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 2, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–29031 Filed 12–8–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pwalker on PROD1PC71 with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
VerDate Aug<31>2005
19:51 Dec 08, 2008
Jkt 217001
74727
provisions set forth in sections
552b(cX4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Prevention and Behavioral
Intervention.
Date: January 15, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Karen Lechter, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3128,
MSC 7759, Bethesda, MD 20892, 301–496–
0726, lechterk@csr.nih.gov.
Name of Committee: Oncological Sciences
Integrated Review Group, Cancer
Immunopathology and Immunotherapy
Study Section.
Date: January 26–27, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Denise R. Shaw, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804,Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Oncological Sciences
Integrated Review Group, Radiation
Therapeutics and Biology Study Section.
Date: January 26–27, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Bo Hong, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–435–5879, hongb@csr.nihgov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated, Review
Group Clinical Neuroimmunology and Brain
Tumors Study Section.
Date: January 29–30, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Jay Joshi, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5196, MSC 7846, Bethesda, MD
20892, (301) 435–1184, joshij@csr.nih.gov.
BILLING CODE 4140–01–M
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Dated: December 2, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–29033 Filed 12–8–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the National Advisory
Council for Complementary and
Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussion could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine.
Date: February 6, 2009.
Closed: 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Open: 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director
of the National Center for Complementary
and Alternative Medicine, presentation of a
new research initiative, and other business of
the Council.
Place: National Institutes of Health,
Neuroscience Building, 6001 Executive
Boulevard, Conference Rooms C & D,
Bethesda, MD 20892.
E:\FR\FM\09DEN1.SGM
09DEN1
74728
Federal Register / Vol. 73, No. 237 / Tuesday, December 9, 2008 / Notices
Contact Person: Martin H. Goldrosen, PhD.,
Executive Secretary. Director, Division of
Extramural Activities. National Center for
Complementary and Alternative Medicine.
National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, (301) 594–2014.
The public comments session is
scheduled from 3:30–4 p.m., but could
change depending on the actual time
spent on each agenda item. Each
speaker will be permitted 5 minutes for
their presentation. Interested
individuals and representatives of
organizations are requested to notify Dr.
Martin H. Goldrosen, National Center
for Complementary and Alternative
Medicine, NIH, 6707 Democracy
Boulevard, Suite 401, Bethesda,
Maryland 20892, 301–594–2014, Fax:
301–480–9970. Letters of intent to
present comments, along with a brief
description of the organization
represented, should be received no later
than 5 p.m. on February 2, 2009. Only
one representative of an organization
may present oral comments. Any person
attending the meeting who does not
request an opportunity to speak in
advance of the meeting may be
considered for oral presentation, if time
permits, and at the discretion of the
Chairperson. In addition, written
comments may be submitted to Dr.
Martin H. Goldrosen at the address
listed above up to ten calendar days
(February 16, 2009) following the
meeting. Copies of the meeting agenda
and the roster of members will be
furnished upon request by contacting
Dr. Martin H. Goldrosen, Executive
Secretary, NACCAM, National Center
for Complementary and Alternative
Medicine, National Institutes of Health,
6707 Democracy Boulevard, Suite 401,
Bethesda, Maryland 20892, 301–594–
2014, Fax 301–480–9970, or via e-mail
at naccames@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for
entrance into the building by nongovernment employees. Persons without
a government I.D. will need to show a
photo I.D. and sign in at the security
desk upon entering the building.
Dated: December 2, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–29030 Filed 12–8–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: SAMHSA Fetal
Alcohol Spectrum Disorders Center for
Excellence Project CHOICES
Evaluation—New
Since 2001, SAMHSA’s Center for
Substance Abuse Prevention has been
operating the SAMHSA Fetal Alcohol
Spectrum Disorders (FASD) Center for
Excellence. The purpose of the FASD
Center for Excellence is to prevent and
improve the treatment of FASD. Some of
the activities of the FASD Center
include providing training, technical
assistance, and subcontracts to increase
the use of effective evidence-based
interventions.
The FASD Center will be integrating
the Project CHOICES program through
service delivery organizations and will
be evaluating the results. Six sites will
implement Project CHOICES with
nonpregnant women 18–44 years who
are sexually active and who are
participating in alcohol treatment
(residential or outpatient) or in drug
treatment (if the women also use
alcohol). Women in substance abuse
treatment will be screened and those
women that meet the above description
will be provided four Motivational
Interviewing (MI) sessions (related to
alcohol use), plus one contraceptive
counseling session. The goal is to help
these women prevent an alcoholexposed pregnancy by abstaining from
alcohol and using contraceptive
methods of their choice consistently and
correctly.
At baseline, an assessment tool will
be administered by the counselor to
assess drinking, sexual activity,
contraceptive use, and demographic
information. At the end of the program,
women are assessed on their alcohol
consumption and contraceptive use in
the past 30 days. At 6 months and 12
months after the end of the program,
women are assessed on alcohol
consumption and contraceptive use
using the same core assessment tool
used at baseline. All participating sites
will maintain personal identification on
their clients for service delivery
purposes but no such information will
be transmitted to SAMHSA.
The data collection is designed to
evaluate the implementation of Project
CHOICES by measuring whether
abstinence from alcohol is achieved and
effective birth control practices are
performed. Furthermore, the project will
include process measures to assess
whether and how the intervention was
provided.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
(6 Sites)
pwalker on PROD1PC71 with NOTICES
Screening tool/activity
Alcohol Use and Contraceptive Methods Assessment ...................................................
Project CHOICES process evaluation assessing whether sessions were delivered and
their duration (75% of baseline) ...................................................................................
VerDate Aug<31>2005
17:00 Dec 08, 2008
Jkt 217001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Number of
responses
per
respondent
Average
burden per
response
913
1
0.25
228
684
5
0.08
274
E:\FR\FM\09DEN1.SGM
09DEN1
Total
burden
hours per
collection
]]>Agencies
[Federal Register Volume 73, Number 237 (Tuesday, December 9, 2008)]
[Notices]
[Pages 74727-74728]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29030]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary and Alternative Medicine;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the National
Advisory Council for Complementary and Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and/or contract
proposals and the discussion could disclose confidential trade secrets
or commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Alternative Medicine.
Date: February 6, 2009.
Closed: 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Open: 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director of the National Center
for Complementary and Alternative Medicine, presentation of a new
research initiative, and other business of the Council.
Place: National Institutes of Health, Neuroscience Building,
6001 Executive Boulevard, Conference Rooms C & D, Bethesda, MD
20892.
[[Page 74728]]
Contact Person: Martin H. Goldrosen, PhD., Executive Secretary.
Director, Division of Extramural Activities. National Center for
Complementary and Alternative Medicine. National Institutes of
Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301)
594-2014.
The public comments session is scheduled from 3:30-4 p.m., but
could change depending on the actual time spent on each agenda item.
Each speaker will be permitted 5 minutes for their presentation.
Interested individuals and representatives of organizations are
requested to notify Dr. Martin H. Goldrosen, National Center for
Complementary and Alternative Medicine, NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax: 301-480-9970.
Letters of intent to present comments, along with a brief description
of the organization represented, should be received no later than 5
p.m. on February 2, 2009. Only one representative of an organization
may present oral comments. Any person attending the meeting who does
not request an opportunity to speak in advance of the meeting may be
considered for oral presentation, if time permits, and at the
discretion of the Chairperson. In addition, written comments may be
submitted to Dr. Martin H. Goldrosen at the address listed above up to
ten calendar days (February 16, 2009) following the meeting. Copies of
the meeting agenda and the roster of members will be furnished upon
request by contacting Dr. Martin H. Goldrosen, Executive Secretary,
NACCAM, National Center for Complementary and Alternative Medicine,
National Institutes of Health, 6707 Democracy Boulevard, Suite 401,
Bethesda, Maryland 20892, 301-594-2014, Fax 301-480-9970, or via e-mail
at naccames@mail.nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government employees.
Persons without a government I.D. will need to show a photo I.D. and
sign in at the security desk upon entering the building.
Dated: December 2, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-29030 Filed 12-8-08; 8:45 am]
BILLING CODE 4140-01-P
